Browsing Tag

antisense

Antisense therapy restores fragile X protein production in human cells: Aberrant alternative…

Jason Junior Jul 6, 2023

An antisense therapy developed by Joel D. Richter, PhD, Sneha Shah, PhD, and Jonathan K. Watts, PhD, at UMass Chan Medical School and Elizabeth Berry-Kravis, MD, PhD, at RUSH University Medical Center, restores production of the protein…

Health

Aligos Discontinues Development of its Antisense Oligonucleotide Drug Candidate ALG-020572 in…

Jason Junior Mar 22, 2022

Dosing in the first cohort discontinued after multiple reports of ALT flares suggestive of drug-induced liver toxicity Funds will be redirected to support ongoing clinical programs, including ALG-000184 (Class-II CAM for CHB) and…

Health

Aligos Therapeutics Begins Dosing with Antisense Oligonucleotide Drug Candidate, ALG-020572, in…

Jason Junior Oct 11, 2021

SOUTH SAN FRANCISCO, Calif., Oct. 11, 2021 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in viral and…

Health

Progenity to Participate in 11th Annual Partnership Opportunities in Drug Delivery Conference

Jason Junior Sep 21, 2021

SAN DIEGO, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, announced today that the company will participate in the 11th annual Partnership Opportunities in Drug Delivery (PODD)…